Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severin Olesen Larsen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Prenatal Diagnosis|July 13, 2002
An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testingMichael Christiansen, Severin Olesen Larsen
Prenatal Diagnosis|June 21, 2005
Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndromeTina Sørensen, Severin Olesen Larsen, Michael Christiansen
BMJ (Clinical Research Ed.)|November 7, 2002
Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screeningMichael Christiansen, Severin Olesen Larsen, Bent Nørgaard-Pedersen
Prenatal Diagnosis|December 1, 2005
Which contingent sequential screening protocol?Severin Olesen Larsen, Michael Christiansen, Bent Norgaard-Pedersen
Ugeskrift for Laeger|October 17, 2002
[Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives]Severin Olesen Larsen, Jan Hansen, Michael Christiansen, et al.
Prenatal Diagnosis|March 5, 2008
First-trimester maternal serum progesterone in aneuploid pregnanciesMichael Christiansen, Tina Lindvig Sørensen, Severin Olesen Larsen, et al.
Prenatal Diagnosis|December 13, 2002
Gender impact on first trimester markers in Down syndrome screeningSeverin Olesen Larsen, Karen R Wøjdemann, Anne-Cathrine Shalmi, et al.
Prenatal Diagnosis|February 2, 2006
Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairsKaren R Wøjdemann, Severin Olesen Larsen, Anne-Cathrine Shalmi, et al.
Prenatal Diagnosis|May 1, 2007
ADAM 12 as a second-trimester maternal serum marker in screening for Down syndromeMichael Christiansen, Kevin Spencer, Jennie Laigaard, et al.
Prenatal Diagnosis|August 8, 2006
ADAM 12 as a first-trimester maternal serum marker in screening for Down syndromeJennie Laigaard, Kevin Spencer, Michael Christiansen, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Prenatal Diagnosis|July 13, 2002
An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testingMichael Christiansen, Severin Olesen Larsen
Prenatal Diagnosis|June 21, 2005
Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndromeTina Sørensen, Severin Olesen Larsen, Michael Christiansen
BMJ (Clinical Research Ed.)|November 7, 2002
Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screeningMichael Christiansen, Severin Olesen Larsen, Bent Nørgaard-Pedersen
Prenatal Diagnosis|December 1, 2005
Which contingent sequential screening protocol?Severin Olesen Larsen, Michael Christiansen, Bent Norgaard-Pedersen
Ugeskrift for Laeger|October 17, 2002
[Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives]Severin Olesen Larsen, Jan Hansen, Michael Christiansen, et al.
Prenatal Diagnosis|March 5, 2008
First-trimester maternal serum progesterone in aneuploid pregnanciesMichael Christiansen, Tina Lindvig Sørensen, Severin Olesen Larsen, et al.
Prenatal Diagnosis|December 13, 2002
Gender impact on first trimester markers in Down syndrome screeningSeverin Olesen Larsen, Karen R Wøjdemann, Anne-Cathrine Shalmi, et al.
Prenatal Diagnosis|February 2, 2006
Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairsKaren R Wøjdemann, Severin Olesen Larsen, Anne-Cathrine Shalmi, et al.
Prenatal Diagnosis|May 1, 2007
ADAM 12 as a second-trimester maternal serum marker in screening for Down syndromeMichael Christiansen, Kevin Spencer, Jennie Laigaard, et al.
Prenatal Diagnosis|August 8, 2006
ADAM 12 as a first-trimester maternal serum marker in screening for Down syndromeJennie Laigaard, Kevin Spencer, Michael Christiansen, et al.
Pageof 3